Impact and prevention of severe exacerbations of COPD: a review of the evidence
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Severe exacerbations of COPD, ie, those leading to hospitalization, have profound clinical implications for patients and significant economic consequences for society. The prevalence and burden of severe COPD exacerbations remain high, despite recognition of the importance of exacerbation prevention and the availability of new treatment options. Severe COPD exacerbations are associated with high mortality, have negative impact on quality of life, are linked to cardiovascular complications, and are a significant burden on the health-care system. This review identified risk factors that contribute to the development of severe exacerbations, treatment options (bronchodilators, antibiotics, corticosteroids [CSs], oxygen therapy, and ventilator support) to manage severe exacerbations, and strategies to prevent readmission to hospital. Risk factors that are amenable to change have been highlighted. A number of bronchodilators have demonstrated successful reduction in risk of severe exacerbations, including long-acting muscarinic antagonist or long-acting β 2 -agonist mono- or combination therapies, in addition to vaccination, mucolytic and antibiotic therapy, and nonpharmacological interventions, such as pulmonary rehabilitation. Recognition of the importance of severe exacerbations is an essential step in improving outcomes for patients with COPD. Evidence-based approaches to prevent and manage severe exacerbations should be implemented as part of targeted strategies for disease management. Keywords: severe COPD exacerbations, hospitalization, prevention, treatment, bronchodilators, long-acting muscarinic antagonist
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self management for patients with chronic obstructive pulmonary disease
Zwerink, M., Brusse-Keizer, M., van der Valk, P. D., Zielhuis, G. A., Monninkhof, E. M., van der Palen, J., Frith, P. A., & Effing, T. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002990.pub3 · Cited by 572 · cited 1×
“…review suggested that overall, the balance of evidence supports the use of self-management programs to reduce the probability of respiratory-related hospitalizations, 111 and the American College of Chest Physicians and Canadian Thoracic Society 107 and ATS/ERS guidelines 12 advocate their use.”
Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression
Gudmundsson, G., Gislason, T., Janson, C., Lindberg, E., Hallin, R., Ulrik, C. S., Brøndum, E., Nieminen, M. M., Aine, T., & Bakke, P. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00078504 · Cited by 366
Fan, V. S., Gaziano, J. M., Lew, R., Bourbeau, J., Adams, S. G., Leatherman, S., Thwin, S. S., Huang, G. D., Robbins, R., Sriram, P. S., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-10-201205150-00003 · Cited by 338 · cited 1×
“However, another randomized trial of patients with COPD found that a home education and management program did not result in a reduction in admissions for exacerbations, and in fact showed an unexpected increase in mortality.(110) A Cochrane review suggested that overall, the balance of evidence supports the use of se…”
Fan, V. S., Curtis, J. R., Tu, S.-P., McDonell, M. B., & Fihn, S. D. (2002) · Chest · doi:10.1378/chest.122.2.429 · Cited by 240 · cited 2×
“6,26,62,64,66 • Impairment in health status and quality of life in COPD is a marker of risk for both frequent exacerbations and hospital admissions.”
Godtfredsen, N. S. (2002) · Thorax · doi:10.1136/thorax.57.11.967 · Cited by 203
Prieto-Centurion, V., Markos, M. A., Ramey, N. I., Gussin, H. A., Nyenhuis, S. M., Joo, M. J., Prasad, B., Bracken, N., DiDomenico, R., Godwin, P. O., et al. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201308-254oc · Cited by 106 · cited 1×
“The US National COPD Readmissions Summit, as well as a recent systematic review, found that the evidence base to support specific interventions that would significantly reduce 30-day readmission rates in patients hospitalized for COPD exacerbations was inadequate.(163,164) Nevertheless, readmission rates are of increa…”
Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit
López-Campos, J. L., Hartl, S., Pozo-Rodriguez, F., Roberts, C. M., & on behalf of the European COPD Audit team (2015) · PLOS ONE · doi:10.1371/journal.pone.0124374 · Cited by 59 · cited 1×
“167 In a study conducted in the US, review of medical records indicated that patients with COPD received only 58% of the care recommended by guidelines.”
Metadata
- Authors
- Halpin, D. M., Miravitlles, M., Metzdorf, N., & Celli, B.
- Venue
- International Journal of Chronic Obstructive Pulmonary Disease
- Publisher
- Informa UK Limited
- Published
- 2017-10
- Volume
- Volume 12
- Pages
- 2891-2908
- ISSN
- 1176-9106 (ISSN-L)
- 1178-2005
- OpenAlex
- W2761298511
- Cited by
- 246
- References
- 8
- FWCI
- 12.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact and prevention of severe exacerbations of COPD: a review of the evidence. https://app.cochat.ai/papers/10.2147/copd.s139470
- The paper
- Halpin, D. M., Miravitlles, M., Metzdorf, N., & Celli, B. (2017). Impact and prevention of severe exacerbations of COPD: a review of the evidence. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s139470
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.